Sanofi Sees Booster Role For Covid Vaccine After Solid But Underwhelming Results

Lower Efficacy In Older Adults

 
• By Andrew McConaghie
  
Sanofi_Berlin
A lower immune response in older adults was the problem which delayed the vaccine's development, but may not have been entirely resolved.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip